Development of the RTS,S/AS malaria candidate vaccineVEKEMANS, Johan; LEACH, Amanda; COHEN, Joe et al.Vaccine. Supplement. 2009, Vol 27, Num 6, issn 1359-5938, G67-G71Conference Paper

Les réponses immunes à médiation cellulaire chez le nouveau-né : vers de nouvelles stratégies vaccinales ciblant les cellules dendritiques = Cell-mediated immunity in newborns : towards new vaccination strategies targeting dendritic cells ?GORIELY, Stanislas; DE WIT, Dominique; FLAMAND, Véronique et al.MS. Médecine sciences. 2001, Vol 17, Num 12, pp 1337-1341, issn 0767-0974Article

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique : a double blind randomised controlled phase I/IIb trial. CommentaryEPSTEIN, Judith E; APONTE, John J; LEACH, Amanda et al.Lancet (British edition). 2007, Vol 370, Num 9598, issn 0140-6736, 1523-1524, 1543-1551 [11 p.]Article

Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development ImplicationsOUATTARA, Amed; TAKALA-HARRISON, Shannon; DIGGS, Carter L et al.The Journal of infectious diseases. 2013, Vol 207, Num 3, pp 511-519, issn 0022-1899, 9 p.Article

HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosisKLEIN, Michèl R; SMITH, Steven M; HAMMOND, Abdulrahman S et al.The Journal of infectious diseases. 2001, Vol 183, Num 6, pp 928-934, issn 0022-1899Article

Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The GambiaVEKEMANS, Johan; LIENHARDT, Christian; SILLAH, Jackson S et al.Infection and immunity. 2001, Vol 69, Num 10, pp 6554-6557, issn 0019-9567Article

Template protocol for clinical trials investigating vaccines—Focus on safety elementsBONHOEFFER, Jan; IMOUKHUEDE, Egeruan B; HOSSAIN, Shah et al.Vaccine. 2013, Vol 31, Num 47, pp 5602-5620, issn 0264-410X, 19 p.Article

Long-Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican ChildrenSACARLAL, Jahit; AIDE, Pedro; VEKEMANS, Johan et al.The Journal of infectious diseases. 2009, Vol 200, Num 3, pp 329-336, issn 0022-1899, 8 p.Article

Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adultsOTA, Martin O. C; VEKEMANS, Johan; SCHLEGEL-HAUETER, Susanna E et al.Vaccine. 2004, Vol 22, Num 3-4, pp 511-519, issn 0264-410X, 9 p.Article

A Field Trial to Assess a Blood-Stage Malaria VaccineTHERA, Mahamadou A; DOUMBO, Ogobara K; DIALLO, Dapa A et al.The New England journal of medicine. 2011, Vol 365, Num 11, pp 1004-1013, issn 0028-4793, 10 p.Article

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_E Malaria Candidate Vaccine When Integrated in the Expanded Program of ImmunizationAGNANDJI, Selidji T; ASANTE, Kwaku Poku; CHIKAWE, Maria et al.The Journal of infectious diseases. 2010, Vol 202, Num 7, pp 1076-1087, issn 0022-1899, 12 p.Article

Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgeBEJON, Philip; LUSINGU, John; DEMOITIE, Marie-Ange et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2521-2532, issn 0028-4793, 12 p.Article

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01_E on Blood Stage Immunity in Young ChildrenBEJON, Philip; COOK, Jackie; DUTTA, Sheetij et al.The Journal of infectious diseases. 2011, Vol 204, Num 1, pp 9-18, issn 0022-1899, 10 p.Article

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialOLOTU, Ally; LUSINGU, John; VANSADIA, Preeti et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 2, pp 102-109, issn 1473-3099, 8 p.Article

Four year immunogenicity of the RTS,S/AS02_A malaria vaccine in Mozambican children during a phase IIb trialAIDE, Pedro; DOBANO, Carlota; HERREROS, Esperanza et al.Vaccine. 2011, Vol 29, Num 35, pp 6059-6067, issn 0264-410X, 9 p.Article

Safety and efficacy of the RTS,S/AS01_E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in InfantsABDULLA, Salim; OBERHOLZER, Rolf; SALIM, Nahya et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2533-2544, issn 0028-4793, 12 p.Article

Dissociation between tuberculin skin test and in vitro IFN-γ responses following neonatal BCG vaccinationOTA, Martin O. C; GOETGHEBUER, Tessa; VEKEMANS, Johan et al.Journal of tropical pediatrics (1980). 2006, Vol 52, Num 2, pp 136-140, issn 0142-6338, 5 p.Article

Immune responses to mycobacterial antigens in the gambian population: implications for vaccines and immunodiagnostic test designVEKEMANS, Johan; OTA, Martin O. C; SILLAH, Jackson et al.Infection and immunity. 2004, Vol 72, Num 1, pp 381-388, issn 0019-9567, 8 p.Article